1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Personalized Medicines Revenue
• 1.4 Market by Type
  • 1.4.1 Global Personalized Medicines Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 PM Diagnostics
  • 1.4.3 PM Therapeutics
  • 1.4.4 Personalized Medical Care
  • 1.4.5 Personalized Nutrition & Wellness
• 1.5 Market by Application
  • 1.5.1 Global Personalized Medicines Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals Pharmacies
  • 1.5.3 Retail Pharmacies
  • 1.5.4 Dietary Care Centers
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Medicines Market Perspective (2015-2026)
• 2.2 Global Personalized Medicines Growth Trends by Regions
  • 2.2.1 Personalized Medicines Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Personalized Medicines Historic Market Share by Regions (2015-2020)
  • 2.2.3 Personalized Medicines Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Personalized Medicines Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Personalized Medicines Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Personalized Medicines Players by Market Size
  • 3.1.1 Global Top Personalized Medicines Players by Revenue (2015-2020)
  • 3.1.2 Global Personalized Medicines Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Personalized Medicines Market Concentration Ratio
  • 3.2.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2019
• 3.3 Personalized Medicines Key Players Head office and Area Served
• 3.4 Key Players Personalized Medicines Product Solution and Service
• 3.5 Date of Enter into Personalized Medicines Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Personalized Medicines Historic Market Size by Type (2015-2020)
• 4.2 Global Personalized Medicines Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Personalized Medicines Market Size by Application (2015-2020)
• 5.2 Global Personalized Medicines Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Personalized Medicines Market Size (2015-2020)
• 6.2 Personalized Medicines Key Players in North America (2019-2020)
• 6.3 North America Personalized Medicines Market Size by Type (2015-2020)
• 6.4 North America Personalized Medicines Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Personalized Medicines Market Size (2015-2020)
• 7.2 Personalized Medicines Key Players in Europe (2019-2020)
• 7.3 Europe Personalized Medicines Market Size by Type (2015-2020)
• 7.4 Europe Personalized Medicines Market Size by Application (2015-2020)

8 China

• 8.1 China Personalized Medicines Market Size (2015-2020)
• 8.2 Personalized Medicines Key Players in China (2019-2020)
• 8.3 China Personalized Medicines Market Size by Type (2015-2020)
• 8.4 China Personalized Medicines Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Personalized Medicines Market Size (2015-2020)
• 9.2 Personalized Medicines Key Players in Japan (2019-2020)
• 9.3 Japan Personalized Medicines Market Size by Type (2015-2020)
• 9.4 Japan Personalized Medicines Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Personalized Medicines Market Size (2015-2020)
• 10.2 Personalized Medicines Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Personalized Medicines Market Size by Type (2015-2020)
• 10.4 Southeast Asia Personalized Medicines Market Size by Application (2015-2020)

11 India

• 11.1 India Personalized Medicines Market Size (2015-2020)
• 11.2 Personalized Medicines Key Players in India (2019-2020)
• 11.3 India Personalized Medicines Market Size by Type (2015-2020)
• 11.4 India Personalized Medicines Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Personalized Medicines Market Size (2015-2020)
• 12.2 Personalized Medicines Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Personalized Medicines Market Size by Type (2015-2020)
• 12.4 Central & South America Personalized Medicines Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 3G Biotech
  • 13.1.1 3G Biotech Company Details
  • 13.1.2 3G Biotech Business Overview
  • 13.1.3 3G Biotech Personalized Medicines Introduction
  • 13.1.4 3G Biotech Revenue in Personalized Medicines Business (2015-2020))
  • 13.1.5 3G Biotech Recent Development
• 13.2 Quest Diagnostics
  • 13.2.1 Quest Diagnostics Company Details
  • 13.2.2 Quest Diagnostics Business Overview
  • 13.2.3 Quest Diagnostics Personalized Medicines Introduction
  • 13.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2015-2020)
  • 13.2.5 Quest Diagnostics Recent Development
• 13.3 Laboratory Corporation of America
  • 13.3.1 Laboratory Corporation of America Company Details
  • 13.3.2 Laboratory Corporation of America Business Overview
  • 13.3.3 Laboratory Corporation of America Personalized Medicines Introduction
  • 13.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2015-2020)
  • 13.3.5 Laboratory Corporation of America Recent Development
• 13.4 Abbott
  • 13.4.1 Abbott Company Details
  • 13.4.2 Abbott Business Overview
  • 13.4.3 Abbott Personalized Medicines Introduction
  • 13.4.4 Abbott Revenue in Personalized Medicines Business (2015-2020)
  • 13.4.5 Abbott Recent Development
• 13.5 Agendia NV
  • 13.5.1 Agendia NV Company Details
  • 13.5.2 Agendia NV Business Overview
  • 13.5.3 Agendia NV Personalized Medicines Introduction
  • 13.5.4 Agendia NV Revenue in Personalized Medicines Business (2015-2020)
  • 13.5.5 Agendia NV Recent Development
• 13.6 Asuragen Inc
  • 13.6.1 Asuragen Inc Company Details
  • 13.6.2 Asuragen Inc Business Overview
  • 13.6.3 Asuragen Inc Personalized Medicines Introduction
  • 13.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2015-2020)
  • 13.6.5 Asuragen Inc Recent Development
• 13.7 Becton Dickinson
  • 13.7.1 Becton Dickinson Company Details
  • 13.7.2 Becton Dickinson Business Overview
  • 13.7.3 Becton Dickinson Personalized Medicines Introduction
  • 13.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2015-2020)
  • 13.7.5 Becton Dickinson Recent Development
• 13.8 CardioDx Inc.
  • 13.8.1 CardioDx Inc. Company Details
  • 13.8.2 CardioDx Inc. Business Overview
  • 13.8.3 CardioDx Inc. Personalized Medicines Introduction
  • 13.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2015-2020)
  • 13.8.5 CardioDx Inc. Recent Development
• 13.9 Foundation Medicine
  • 13.9.1 Foundation Medicine Company Details
  • 13.9.2 Foundation Medicine Business Overview
  • 13.9.3 Foundation Medicine Personalized Medicines Introduction
  • 13.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2015-2020)
  • 13.9.5 Foundation Medicine Recent Development
• 13.10 Qiagen
  • 13.10.1 Qiagen Company Details
  • 13.10.2 Qiagen Business Overview
  • 13.10.3 Qiagen Personalized Medicines Introduction
  • 13.10.4 Qiagen Revenue in Personalized Medicines Business (2015-2020)
  • 13.10.5 Qiagen Recent Development
• 13.11 Siemens Healthcare
  • 10.11.1 Siemens Healthcare Company Details
  • 10.11.2 Siemens Healthcare Business Overview
  • 10.11.3 Siemens Healthcare Personalized Medicines Introduction
  • 10.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2015-2020)
  • 10.11.5 Siemens Healthcare Recent Development
• 13.12 Amgen
  • 10.12.1 Amgen Company Details
  • 10.12.2 Amgen Business Overview
  • 10.12.3 Amgen Personalized Medicines Introduction
  • 10.12.4 Amgen Revenue in Personalized Medicines Business (2015-2020)
  • 10.12.5 Amgen Recent Development
• 13.13 Bristol-Myers Squibb
  • 10.13.1 Bristol-Myers Squibb Company Details
  • 10.13.2 Bristol-Myers Squibb Business Overview
  • 10.13.3 Bristol-Myers Squibb Personalized Medicines Introduction
  • 10.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2015-2020)
  • 10.13.5 Bristol-Myers Squibb Recent Development
• 13.14 GE Healthcare
  • 10.14.1 GE Healthcare Company Details
  • 10.14.2 GE Healthcare Business Overview
  • 10.14.3 GE Healthcare Personalized Medicines Introduction
  • 10.14.4 GE Healthcare Revenue in Personalized Medicines Business (2015-2020)
  • 10.14.5 GE Healthcare Recent Development
• 13.15 Pfizer
  • 10.15.1 Pfizer Company Details
  • 10.15.2 Pfizer Business Overview
  • 10.15.3 Pfizer Personalized Medicines Introduction
  • 10.15.4 Pfizer Revenue in Personalized Medicines Business (2015-2020)
  • 10.15.5 Pfizer Recent Development
• 13.16 Sanofi
  • 10.16.1 Sanofi Company Details
  • 10.16.2 Sanofi Business Overview
  • 10.16.3 Sanofi Personalized Medicines Introduction
  • 10.16.4 Sanofi Revenue in Personalized Medicines Business (2015-2020)
  • 10.16.5 Sanofi Recent Development
• 13.17 23andMe
  • 10.17.1 23andMe Company Details
  • 10.17.2 23andMe Business Overview
  • 10.17.3 23andMe Personalized Medicines Introduction
  • 10.17.4 23andMe Revenue in Personalized Medicines Business (2015-2020)
  • 10.17.5 23andMe Recent Development
• 13.18 Illumina
  • 10.18.1 Illumina Company Details
  • 10.18.2 Illumina Business Overview
  • 10.18.3 Illumina Personalized Medicines Introduction
  • 10.18.4 Illumina Revenue in Personalized Medicines Business (2015-2020)
  • 10.18.5 Illumina Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Personalized Medicines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina

Market segment by Type, the product can be split into
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America